Astera Labs (ALAB) EBIT (2023 - 2026)

Astera Labs (ALAB) has reported EBIT for 4 consecutive years, with $89.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBIT rose 124.39% year-over-year to $89.2 million; the trailing twelve-month figure through Jun 2026 stood at $273.4 million (up 546.34% YoY), and the FY2025 full-year result was $173.4 million, up 249.42% from the prior year.
• EBIT rose to $89.2 million in Q2 2026 per ALAB's latest filing, from $61.8 million in the prior quarter.
• Across five years, EBIT topped out at $89.2 million in Q2 2026 and bottomed at -$83.0 million in Q1 2024.
• Historically, EBIT has averaged $12.8 million across 4 years, with a median of $4.6 million in 2023.
• The sharpest annual moves came in 2024 and 2025: EBIT sank 349.97% in 2024, then soared 46398.61% in 2025.
• Over 4 years, EBIT stood at $9.0 million in 2023, then plunged by 98.4% to $144000.0 in 2024, then jumped by 46398.61% to $67.0 million in 2025, then surged by 33.29% to $89.2 million in 2026.
• According to Business Quant data, EBIT over the past three periods registered $89.2 million, $61.8 million, and $67.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.